19 year old male's three month results from using a combination of Minoxidil, finasteride and dermarolling for hair loss. It was suggested that adding Minoxidil could help with further progress.
A user discusses using a mix of 10% CBD oil and emu oil for hair regrowth, seeking help to apply 3-4 mg daily. They mention needing 0.5-1ml to cover their buzzed scalp.
A 37-year-old male stopped using finasteride and minoxidil due to side effects and switched to derma rolling, scalp massaging, and Revita shampoo, resulting in thicker, healthier hair with new growth. Users discuss the effectiveness of mechanical scalp stimulation, with some sharing similar positive experiences and others expressing skepticism.
Breezula (clascoterone) Phase 3 hair loss trial results are delayed, with no official updates yet. The acne version is approved, but hair loss results are still pending.
The conversation humorously discusses hair loss treatments, specifically mentioning Minoxidil, finasteride, and RU58841. It highlights a funny brand name found on Amazon related to derma stamps.
A 25-year-old male experienced noticeable temple regrowth using 1mg finasteride, 2.5mg oral minoxidil, and 2mg GHK-Cu over three months. The user is pleased with the progress, especially on the left temple.
A 30-year-old male is experiencing some hair regrowth after 77 days using oral finasteride, topical minoxidil 5%, and a 0.5mm derma roller twice a week. Users note small hairs filling previously smooth spots, but it's too early to determine full regrowth potential.
The user is considering using CB or clascoterone for hair loss, potentially as an alternative to RU. They're also contemplating asking a dermatologist for topical clascoterone cream to apply to their temple.
A 30-year-old is experiencing positive hair growth results using finasteride daily, minoxidil twice daily, and dermastamping/dermarolling biweekly from July 2025 to January 2026. Friends and family have noticed significant improvement.
AH-001 is a new topical treatment designed to degrade androgen receptors, targeting the root cause of androgenetic alopecia without the side effects of oral treatments like finasteride. It has shown a strong safety profile and good local tolerability in early trials.
A user gained 10-12 kg after starting finasteride but found their estrogen levels to be within the normal range. They are concerned about potential gynecomastia but are reassured by their lab results.
The user switched from finasteride to dutasteride for hair loss treatment, also using topical minoxidil, micro needling, keto shampoo, and PRP sessions. They've seen improvements, with reduced hair shedding and new hair growth, especially at the hairline.
The conversation is about a 22-year-old using dutasteride and topical minoxidil for hair regrowth, showing significant improvement in hair thickness and temple regrowth. Users commend the progress and inquire about the specific routine and dosage.
A 26-year-old man with diffuse alopecia is using electric scalp massage, dermastamp, and multivitamins for treatment but is intolerant to finasteride. A dermatologist recommended PRP and mesotherapy with exosomes and dutasteride.
A 51-year-old man uses 1mg oral finasteride daily, 5% topical minoxidil twice daily, dermarolling, and Nizoral twice a week for hair regrowth. He shows significant progress after two months and is happy with the improvement.
A new topical treatment, TH07, combining finasteride, latanoprost, and minoxidil, is entering phase III trials with promising early results. Some users express skepticism, noting the treatment uses existing products.
A 32-year-old man from Vietnam, at Norwood 7 hair loss, is using Minoxidil, Finasteride, rosemary oil, NMN, and CoQ10 to regrow hair. Despite minor improvements, alternatives like hair systems or accepting baldness are suggested due to advanced hair loss.
The user is considering adding an anti-androgen, RU58841, to their current hair loss treatment routine due to receding hair. They are also contemplating waiting for Breezula or Pyrilutamide to become more affordable.
The conversation is about finding a reliable Chinese source for pyrilutamide or RU58841, ideally with a third-party Certificate of Analysis from Janoshik Analytical. The user is seeking recommendations for these hair loss treatments.
Bimatoprost 1% and 3% solutions showed better hair regrowth than minoxidil 5%. The user plans to test a homemade bimatoprost solution on their scalp and share results.
A 25-year-old shares 4 months of hair loss progress using 0.5mg Dutasteride, 2.5mg Minoxidil, and 10mg Biotin in one capsule. They experienced significant improvement by month 2, despite a big shed at month 3, with no side effects reported.
A 31-year-old man shared his hair growth progress from July 2024 to March 2026 using oral finasteride (1mg) and minoxidil (2.5mg), with no significant side effects. He is considering switching treatments but is advised to continue with the current regimen due to its effectiveness.
A 23-year-old male had a hair transplant with 3500 grafts and is using finasteride, minoxidil, hair vitamins, and a keto shampoo. He seeks advice on crown regrowth and when to start dermastamping.
A 36-year-old male has been using finasteride, 5% minoxidil foam, and microneedling with a 0.75mm dermastamp or Dr. pen for three months. He notices thicker hair and reduced hair loss, with high testosterone and normal DHT levels, while managing prolactin levels with vitamin B6.
An 18-year-old is using a high-dose hair loss treatment regimen including finasteride, minoxidil, dutasteride, and plans to add RU58841 and bimatoprost, despite warnings from others about the risks. The user is determined to reverse hair loss but acknowledges the potential dangers and does not recommend others follow their approach.
The user is experiencing good hair regrowth using topical minoxidil, oral finasteride, biotin, and ketoconazole shampoo. They are curious about when the regrowth will plateau.
KY19382 is discussed as a potential treatment for creating new hair follicles and possibly curing hair loss. The conversation seeks user experiences and sourcing information for KY19382.